Abstract
It has been suggested that use of cardiovascular risk tables in hypertensive patients might improve clinical management. As part of a randomised controlled trial, we evaluated the accuracy of health professionals' use of the New Zealand risk tables in primary care consultations. Chance-corrected agreement between health professionals' assessments of absolute risk was only moderate (weighted kappa = 0.56 at the 12-month follow-up). Inaccurate use of cardiovascular risk tables may be a barrier to effective implementation of research evidence in the management of hypertension.
Full Text
The Full Text of this article is available as a PDF (28.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Haq I. U., Jackson P. R., Yeo W. W., Ramsay L. E. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet. 1995 Dec 2;346(8988):1467–1471. doi: 10.1016/s0140-6736(95)92477-9. [DOI] [PubMed] [Google Scholar]
- Haynes B., Haines A. Barriers and bridges to evidence based clinical practice. BMJ. 1998 Jul 25;317(7153):273–276. doi: 10.1136/bmj.317.7153.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Myers M. G., Carruthers S. G., Leenen F. H., Haynes R. B. Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension. CMAJ. 1989 May 15;140(10):1141–1146. [PMC free article] [PubMed] [Google Scholar]
- Sever P., Beevers G., Bulpitt C., Lever A., Ramsay L., Reid J., Swales J. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ. 1993 Apr 10;306(6883):983–987. doi: 10.1136/bmj.306.6883.983. [DOI] [PMC free article] [PubMed] [Google Scholar]